Shelby, North Carolina Clinical Trials

A listing of Shelby, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Galderma Investigational Site 8795
 (1.8 away) Contact site
  • 21 views
  • 04 Aug, 2021
  • +474 other locations
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the efficacy of Dupilumab in the treatment of signs and symptoms of atopic keratoconjunctivitis (AKC).

The Eye Care Institute
 (305.6 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +4 other locations
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients

The purpose of this study is to support the dose selection for future studies by evaluating efficacy and safety of different QBW251 doses in COPD patients with chronic bronchitis and a history of exacerbations, compared to placebo, when added to a triple combination therapy of LABA, LAMA and ICS with …

bronchitis
Novartis Investigative Site
 (24.2 away) Contact site
  • 176 views
  • 04 Aug, 2021
  • +173 other locations
Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)

Novartis Investigative Site
 (1.8 away) Contact site
  • 143 views
  • 04 Aug, 2021
  • +547 other locations
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in …

fever
headache
sore throat
myalgia
cough
VITALINK - Gaffney
 (17.3 away) Contact site
  • 2402 views
  • 02 Aug, 2021
  • +214 other locations
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

The purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

VitaLink Research Gaffney
 (17.3 away) Contact site
  • 17 views
  • 25 Jul, 2021
  • +110 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in COPD participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 57 weeks, consisting of 2 …

corticosteroids
copd exacerbation
fluticasone
albuterol
eosinophil count
GSK Investigational Site
 (18.0 away) Contact site
  • 379 views
  • 24 Jul, 2021
  • +232 other locations
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

This will be a 2 stage study in which Stage 1 will evaluate the safety of AGN-242428 and AGN-231868, how well they are tolerated and how they move through the body when administered. After the sponsor's determination of adequate safety and tolerability of the interventions in Stage 1, Stage 2 …

anesthesia
eye disease
schirmer's test
Vita Eye Clinic /ID# 232721
 (1.8 away) Contact site
  • 45 views
  • 21 Jul, 2021
  • +9 other locations
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

This study will assess tolerability, safety, and pharmacodynamics (PD) of twice daily (BID) administration of PF- 06882961 in adult participants with Type 2 Diabetes Mellitus (T2DM) who are treated with metformin and in non-diabetic adults with obesity

a 12
metformin
type 2 diabetes mellitus
diabetes
PMG Research of Hickory, LLC
 (28.1 away) Contact site
  • 1 views
  • 04 Aug, 2021
  • +40 other locations